RKDA — Arcadia Biosciences Share News
0.000.00%
Last trade - 00:00- $0.39m
- -$3.79m
- $4.86m
Arcadia Biosciences Inc expected to post a loss of $4.80 a share - Earnings Preview
Brief: Arcadia Biosciences Announces Strategic Review
Brief: Arcadia Biosciences (Rkda) Announces First Quarter 2023 Financial Results From Operations And Business Highlights
Arcadia Biosciences Inc expected to post a loss of $6.85 a share - Earnings Preview
Brief: Arcadia Biosciences Files Prospectus Covers Sale Or Other Disposition From Time To Time Of Up To 2.03 Million Common Shares By Selling Stockholders
Arcadia Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Arcadia Biosciences Announces Fourth-Quarter And Full-Year 2022 Financial Results And Business Highlights
Arcadia Biosciences Inc expected to post a loss of $6.80 a share - Earnings Preview
Brief: Arcadia Biosciences Says $6.0 Million Private Placement Priced At A Premium To Market
Brief: Arcadia Biosciences Inc - On Feb 27, Filed Certificate Of Amendment To Effect 1-For-40 Reverse Stock Split Of Outstanding Shares Of Co's Common Stock
Brief: Arcadia Biosciences Announces CFO Transition
Brief: Arcadia Biosciences Announces Third Quarter 2022 Financial Results And Business Highlights
Arcadia Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Arcadia Biosciences Inc expected to post a loss of 21 cents a share - Earnings Preview
Arcadia Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Arcadia Biosciences Q2 Revenue $3.9 Million Versus $1.4 Million
Arcadia Biosciences Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Arcadia Biosciences - On June 2, Stanley E. Jacot, Jr., Arcadia's Current President And CEO, To Serve As A Class III Director Of Company
Brief: Arcadia Biosciences Announces First Quarter 2022 Financial Results